23CUR057: Phase I Non-Randomized, Unblinded, Single-Center Trial of Oral Telmisartan Alone or Combined with Selected Standard of Care Therapies for Prostate Cancer

Principal Investigator

Rodwell Mabaera

Study Number

STUDY02002057

Summary

The goal of this clinical trial is to learn about the tolerability of telmisartan in patients with prostate cancer.

Phase

I

Available at the following location(s)

• Lebanon

View more details at ClinicalTrials.gov

Do you need help with some of the labels on this page?
Read our glossary of terms